Fatty liver epidemiology and demographics: Difference between revisions
| Line 6: | Line 6: | ||
== Overview== | == Overview== | ||
Fatty liver disease is prevalent among 10%- 24% of general population in various countries.<ref name="angulo"/> However among obese individuals the condition is observed in up to 75% of people, 35% of whom, despite no evidence of excessive alcohol consumption, will lead to [[Non-alcoholic fatty liver disease|non alcoholic FLD]].<ref>{{cite journal |author=Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J, Ida K |title=The metabolic syndrome as a predictor of nonalcoholic fatty liver disease |journal=Ann. Intern. Med. |volume=143 |issue=10 |pages=722-8 |year=2005 |pmid=16287793 |doi=}}</ref> It is the | Fatty liver disease is prevalent among 10%- 24% of general population in various countries.<ref name="angulo"/> However among obese individuals the condition is observed in up to 75% of people, 35% of whom, despite no evidence of excessive alcohol consumption, will lead to [[Non-alcoholic fatty liver disease|non alcoholic FLD]].<ref>{{cite journal |author=Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J, Ida K |title=The metabolic syndrome as a predictor of nonalcoholic fatty liver disease |journal=Ann. Intern. Med. |volume=143 |issue=10 |pages=722-8 |year=2005 |pmid=16287793 |doi=}}</ref> It is the most common cause of abnormal [[liver function test]] in the US.<ref name="angulo">{{cite journal |author=Angulo P |title=Nonalcoholic fatty liver disease |journal=N. Engl. J. Med. |volume=346 |issue=16 |pages=1221-31 |year=2002 |pmid=11961152 |doi=10.1056/NEJMra011775}}</ref> African Americans and Mexican Americans have higher frequencies of unexplained serum [[Transaminase|aminotransferase]] elevations than those reported in whites but prevalence of FLD among different racial groups is not known. | ||
==References== | ==References== | ||
Revision as of 15:18, 7 March 2013
|
Fatty Liver Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fatty liver epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Fatty liver epidemiology and demographics |
|
Risk calculators and risk factors for Fatty liver epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Fatty liver disease is prevalent among 10%- 24% of general population in various countries.[1] However among obese individuals the condition is observed in up to 75% of people, 35% of whom, despite no evidence of excessive alcohol consumption, will lead to non alcoholic FLD.[2] It is the most common cause of abnormal liver function test in the US.[1] African Americans and Mexican Americans have higher frequencies of unexplained serum aminotransferase elevations than those reported in whites but prevalence of FLD among different racial groups is not known.
References
- ↑ 1.0 1.1 Angulo P (2002). "Nonalcoholic fatty liver disease". N. Engl. J. Med. 346 (16): 1221–31. doi:10.1056/NEJMra011775. PMID 11961152.
- ↑ Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J, Ida K (2005). "The metabolic syndrome as a predictor of nonalcoholic fatty liver disease". Ann. Intern. Med. 143 (10): 722–8. PMID 16287793.